Advanced search
Publication Cover
Journal of Investigative Surgery Volume 30, 2017 - Issue 4
Submit an article Journal homepage
112
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Expression of TRAIL and Fas in Primary Hyperparathyroidism

Oliwia Anna SegietDepartment of Histology and Embryology, School of Medicine with the Division of Dentistry, Medical University of Silesia, Jordana 19, Zabrze, PolandCorrespondence[email protected]
,
Mariusz DeskaDepartment of General and Endocrine Surgery, School of Medicine with the Division of Dentistry, Medical University of Silesia, Stefana Batorego 15, Bytom, Poland
,
Łukasz MielańczykDepartment of Histology and Embryology, School of Medicine with the Division of Dentistry, Medical University of Silesia, Jordana 19, Zabrze, Poland
,
Marlena Brzozowa-ZasadaDepartment of Histology and Embryology, School of Medicine with the Division of Dentistry, Medical University of Silesia, Jordana 19, Zabrze, Poland
,
Grzegorz BułaDepartment of General and Endocrine Surgery, School of Medicine with the Division of Dentistry, Medical University of Silesia, Stefana Batorego 15, Bytom, Poland
,
Jacek GawrychowskiDepartment of General and Endocrine Surgery, School of Medicine with the Division of Dentistry, Medical University of Silesia, Stefana Batorego 15, Bytom, Poland
&
Romuald WojniczDepartment of Histology and Embryology, School of Medicine with the Division of Dentistry, Medical University of Silesia, Jordana 19, Zabrze, Poland
 show all
Pages 242-246 | Received 24 May 2016, Accepted 09 Sep 2016, Published online: 20 Oct 2016

REFERENCES

  • Fraser WD. Hyperparathyroidism. Lancet 2009;374:145–158.
  • Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner. 2002;17(Suppl 2):18–23.
  • Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81:2036–2040.
  • Irvin GL, Carneiro D. Management changes in primary hyperparathyroidism. JAMA 2000;284:934–936.
  • Clark OH.Surgical treatment of primary hyperparathyroidism. Adv Endocrinol Metab. 1995;6:1–9.
  • Kimberley FC, Screaton GR. Following a TRAIL: update on a ligand and its five receptors. Cell Res. 2004;14:359–372.
  • Tecchio C, Huber V, Scapini P, et al. IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. Blood 2004;103:3837–3844.
  • Corazza N, Kassahn D, Jakob S, et al. TRAIL-induced apoptosis: between tumor therapy and immunopathology. Ann N Y Acad Sci. 2009;1171:50–58.
  • Stuckey DW, Shah K. TRAIL on trial: preclinical advances in cancer therapy. Trends Mol Med. 2013;19:685–694.
  • Mori K, Emoto M, Inaba M. Multifunctional role of TRAIL in atherosclerosis and cardiovascular disease. In: Advances in the Diagnosis of Coronary Atherosclerosis, Kiraç SF, ed. Rijeka, Croatia: In Tech; 2011:19–32.
  • Mori K, Ikari Y, Jono S, et al. Association of serum TRAIL level with coronary artery disease. Thromb Res. 2010;125:322–325.
  • Michowitz Y, Goldstein E, Roth A, et al. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J Am Coll Cardiol. 2005;45:1018–1024.
  • Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J. 2009;23:1625–1637.
  • Son JK, Varadarajan S, Bratton SB. TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1. Cell Death Differ. 2010;17:1288–1301.
  • Schneider P, Thome M, Burns K, et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997;7:831–836.
  • Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003;10:26–35.
  • Nagata S.Apoptosis by death factor. Cell 1997;88:355–365.
  • Krammer PH.CD95′s deadly mission in the immune system. Nature 2000;407:789–795.
  • Peter ME, Barnhart BC, Algeciras-Schimnich A. The cytokine handbook: CD95L/FasL and its receptor CD95 (APO-1/Fas). Cytokine Handbook 2003;2:885–911.
  • Árvai K, Nagy K, Barti-Juhász H et al. Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma. Pathol Oncol Res. 2012;18(3):607–614.
  • Szende B, Árvai K, Peták I, et al. Changes in gene expression in the course of proliferative processes in the parathyroid gland. Magy Onkol. 2006;50(2):137–140.
  • Wang W, Johansson H, Kvasnicka T, et al. Detection of apoptotic cells and expression of Ki-67 antigen, bcl-2, p53 oncoproteins in human parathyroid adenoma. Acta Pathol Microbiol Scand. 1996;104:789–796.
  • Thomopoulou GE, Tseleni-Balafouta S, Lazaris AC, et al. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions. Eur J Endocrinol. 2003;148(1):81–87.
  • Szende B, Farid P, Vegso G, et al. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Pathol Oncol Res. 2004;10(2):98–103.
  • Kvasnicka T, Wang W, Johansson H, et al. Apoptosis and growth factors in parathyroid adenomas. Horm Metab Res. 1997;29(11):544–548.
  • Hadar T, Shvero J, Yaniv E, et al. Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Pathol Oncol Res. 2005;11(1):45–49.
  • Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 2011;21:92–101.
  • Vargas MP, Vargas HI, Kleiner DE, Merino MJ. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol. 1997;10(1):12–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.